Cardio Diagnostics Holdings, Inc. (CDIO)
1.92
+0.01
(+0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.99
+0.07
(+3.65%)
After-Hours: 19:59
Cardio Diagnostics Holdings Research and Development Expense (Annual) : 0.6412M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.6412M |
| December 31, 2024 | 0.0291M |
| December 31, 2023 | 0.1452M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0404M |
| December 31, 2021 | 0.0315M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tenax Therapeutics, Inc. | 32.67M |
| Exicure, Inc. | 3.286M |
| Century Therapeutics, Inc. | 82.57M |
| Absci Corp. | 80.72M |
| Celularity, Inc. | 9.222M |